Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
6.38T | 6.08T | 5.91T | 5.69T | 5.21T | 4.86T | Gross Profit |
3.09T | 2.93T | 2.72T | 2.80T | 2.50T | 2.32T | EBIT |
924.75B | 851.58B | 1.06T | 985.75B | 970.77B | 911.73B | EBITDA |
1.70T | 1.61T | 1.52T | 1.73T | 1.66T | 1.55T | Net Income Common Stockholders |
519.00B | 489.07B | 531.37B | 517.08B | 491.29B | 473.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.89T | 1.99T | 2.25T | 1.74T | 1.73T | 1.24T | Total Assets |
16.30T | 15.52T | 14.68T | 12.71T | 12.23T | 9.79T | Total Debt |
6.22T | 6.32T | 6.13T | 6.00T | 5.69T | 5.08T | Net Debt |
4.32T | 4.33T | 4.08T | 4.45T | 4.11T | 3.94T | Total Liabilities |
12.14T | 11.59T | 11.00T | 9.82T | 9.48T | 8.08T | Stockholders Equity |
2.65T | 2.38T | 2.22T | 1.68T | 1.51T | 1.00T |
Cash Flow | Free Cash Flow | ||||
883.00B | 685.62B | 546.53B | 506.83B | 859.43B | 817.75B | Operating Cash Flow |
1.46T | 1.24T | 1.16T | 1.22T | 1.34T | 1.25T | Investing Cash Flow |
-923.44B | -927.61B | -154.77B | -957.69B | -511.30B | -900.14B | Financing Cash Flow |
-850.79B | -391.30B | -495.26B | -305.07B | -388.46B | -143.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.44T | 20.02 | 3.91% | 7.57% | 6.30% | ||
80 Outperform | $13.51T | 13.25 | 9.84% | 3.18% | 2.47% | -20.86% | |
76 Outperform | ¥233.58B | 19.06 | 12.86% | 2.58% | 8.11% | 6.48% | |
73 Outperform | $510.98B | 25.20 | 14.78% | 1.17% | 14.76% | 0.69% | |
70 Outperform | $9.12T | 14.24 | 13.04% | 2.94% | 2.85% | 12.63% | |
65 Neutral | ¥10.77T | 9.43 | 10.28% | 0.57% | 7.21% | ― | |
61 Neutral | $14.59B | 5.85 | -4.31% | 3.69% | 2.76% | -30.36% |